Acuamark Diagnostics

About:

Acuamark develops technology that allows for highly accurate screening of blood to detect cancer markers at early cancer stages.

Website: http://acuamarkdx.com/

Twitter/X: AcuamarkDx

Top Investors: Claudio Del Vecchio

Description:

Acuamark Diagnostics develops technology that allows for a highly accurate screening of blood to detect cancer markers at the early cancer stages before cancer becomes untreatable. Backed by a highly experienced team of scientific and business professionals, it is its mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection. It was founded in 2012 and is headquartered in New York, New York.

Total Funding Amount:

$13.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)acuamarkdx.com

Founders:

Bernard Peperstraete, Francis Barany

Number of Employees:

1-10

Last Funding Date:

2022-04-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai